Jan 09, 2024 / 05:00PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team, I'm here with Illumina up on stage. So as these sessions are, it's going to be 40 minutes, roughly 20 minutes of presentations upfront and then followed by 20 minutes of Q&A. And with that, I will pass it off to Jacob.
Jacob Thaysen - Illumina, Inc. - CEO & Director
Thanks. Thanks, Rachel, and for JPMorgan for hosting us here today and for all of you joining us here in the room. I am Jacob Thaysen, the CEO of Illumina. And as a reminder, our presentation today includes some very exciting things here, including forward-looking statements, non-GAAP measures and information about their relations to GAAP measures. Please refer to our SEC filings for presentation of risks. Also, please review the statements of our whole separate requirements related to GRAIL, GRAIL must be held and operated separately and independently for Illumina related to the order of the European
Illumina Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers